GenoMar provides genetically superior tilapia strains developed through advanced selective breeding and genomic selection. Their genetics enhance farm productivity and resilience by focusing on growth rate, fillet yield, and disease resistance, leading to improved operational efficiency and profitability for aquaculture producers.
Funding
Funding not disclosed
Founders
Product
Problem
Aquaculture operations face challenges in achieving consistent profitability due to the inherent variability in fish growth rates and susceptibility to diseases. Traditional breeding methods often result in slow genetic progress, failing to meet the increasing demands for efficient and robust production systems. This limits the potential for yield optimization and increases the risk of economic losses from disease outbreaks.
Solution
GenoMar provides genetically superior tilapia strains developed through advanced selective breeding programs. By focusing on key performance indicators such as growth rate, fillet yield, and disease resistance, GenoMar's genetics enhance the productivity and resilience of aquaculture farms. The company leverages over three decades of research and development, incorporating genomic selection and advanced breeding technologies to deliver consistent genetic gains. This approach ensures that farmers receive high-quality, predictable stock that contributes to improved operational efficiency and profitability. GenoMar's commitment extends to maintaining stringent biosecurity standards, ensuring the health and integrity of their genetic material from nucleus to distribution.
Target Audience
The primary customers are tilapia farmers, aquaculture producers, and hatcheries seeking to improve their stock's performance, disease resistance, and overall profitability. This includes large-scale commercial operations and integrated aquaculture businesses.
Features
- **Selective Breeding Program:** Over 30 years of continuous genetic improvement in Nile tilapia (_Oreochromis niloticus_) focusing on growth, fillet yield, and disease resistance.
- **Genomic Selection:** Utilization of SNP panels (up to 70,000 SNPs) for precise genomic evaluation and selection of breeding candidates, enhancing prediction accuracy for complex traits.
- **Marker-Assisted Selection (MAS):** Application of DNA markers to construct pedigrees and improve the accuracy of genetic evaluations, particularly for traits not easily measured on live candidates.
- **BLUP Methodology:** Employment of Best Linear Unbiased Prediction (BLUP) for accurate genetic merit estimation, accounting for environmental factors and family relationships.
- **Line and Cross-Breeding Strategies:** Development of distinct breeding lines and implementation of cross-breeding programs to leverage heterosis and optimize performance for specific market demands.
- **Specific Pathogen Free (SPF) Certification:** Adherence to rigorous biosecurity protocols, with SPF certification for key breeding centers, guaranteeing freedom from significant viral pathogens like TiLV and Iridovirus.
- **CT Scanning for Carcass Traits:** Integration of medical-grade Computed Tomography (CT) scanning and machine learning for detailed, non-invasive measurement of carcass traits, including muscle volume, to improve fillet yield selection.
- **Two Distinct Brands:** Offering differentiated genetic products through the GenoMar (GenoMar 1000 for growth/yield, GenoMar STRONG for robustness/survival) and Aquabel brands.